COVID-19 in patients with cardiovascular diseases.
作者信息
Hulot Jean-Sébastien
机构信息
Université de Paris, Inserm, PARCC, 75015 Paris, France; CIC1418 and DMU CARTE, hôpital européen Georges-Pompidou, AP-HP, 56, rue Leblanc, 75015 Paris, France.
出版信息
Arch Cardiovasc Dis. 2020 Apr;113(4):225-226. doi: 10.1016/j.acvd.2020.03.009. Epub 2020 Mar 31.
Abstract
摘要
相似文献
1
COVID-19 in patients with cardiovascular diseases.心血管疾病患者中的新型冠状病毒肺炎
Arch Cardiovasc Dis. 2020 Apr;113(4):225-226. doi: 10.1016/j.acvd.2020.03.009. Epub 2020 Mar 31.
2
Cardiovascular disease, heart failure and COVID-19.心血管疾病、心力衰竭与2019冠状病毒病
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926903. doi: 10.1177/1470320320926903.
3
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
4
Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications.致编辑的信：血管紧张素转换酶2：盟友还是特洛伊木马？对SARS-CoV-2相关心血管并发症的影响
Am J Physiol Heart Circ Physiol. 2020 May 1;318(5):H1080-H1083. doi: 10.1152/ajpheart.00215.2020. Epub 2020 Mar 30.
5
COVID-19 and the Heart.新型冠状病毒肺炎与心脏
Arq Bras Cardiol. 2020 Apr;114(4):598-600. doi: 10.36660/abc.20200209. Epub 2020 Mar 30.
6
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.2019冠状病毒病与心血管系统：影响与启示。
Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.
7
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应？
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
8
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science.2019冠状病毒病、衰老与心血管疾病的困境：心血管衰老科学的见解
JAMA Cardiol. 2020 Jul 1;5(7):747-748. doi: 10.1001/jamacardio.2020.1329.
9
COVID-19 and Cardiovascular Disease.新型冠状病毒肺炎与心血管疾病。
Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21.
10
[Cardiovascular implications of SARS-CoV-2 infection: A literature review].[新型冠状病毒2019感染的心血管影响：文献综述]
Medwave. 2020 Aug 28;20(7):e8008. doi: 10.5867/medwave.2020.07.8008.
引用本文的文献
1
The community proactive health management model based on the grounded theory: The case of Beijing, China.基于扎根理论的社区主动健康管理模式：以中国北京为例
Heliyon. 2023 Apr;9(4):e14992. doi: 10.1016/j.heliyon.2023.e14992. Epub 2023 Apr 4.
2
Flexible Label-Free Platinum and Bio-PET-Based Immunosensor for the Detection of SARS-CoV-2.基于生物-PET 的灵活无标记铂免疫传感器用于检测 SARS-CoV-2。
Biosensors (Basel). 2023 Jan 26;13(2):190. doi: 10.3390/bios13020190.
3
Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon.在加蓬利伯维尔接受羟氯喹或氯喹治疗的新冠病毒疾病患者中QTc的早期改变
Clin Pract. 2022 Jun 30;12(4):482-490. doi: 10.3390/clinpract12040052.
4
Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.法国 COVID-19 住院患者的特征和结局：Critical COVID-19 France（CCF）研究。
Arch Cardiovasc Dis. 2021 May;114(5):352-363. doi: 10.1016/j.acvd.2021.01.003. Epub 2021 Mar 2.
5
Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case.建模 2019 年冠状病毒病患者的心脏性猝死风险因素：羟氯喹和阿奇霉素的案例。
Europace. 2021 Jul 18;23(7):1124-1133. doi: 10.1093/europace/euab043.
6
Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research.重症监护病房中严重急性呼吸综合征冠状病毒2感染与器官功能障碍：转化研究的机遇
Crit Care Explor. 2021 Mar 12;3(3):e0374. doi: 10.1097/CCE.0000000000000374. eCollection 2021 Mar.
7
The frequency of arrhythmias in COVID-19 patients, a study in the Shahid Mostafa Khomeini Hospital of Ilam from March to August 2020.2020年3月至8月在伊拉姆省沙希德·穆斯塔法·霍梅尼医院进行的一项研究：COVID-19患者心律失常的发生率。
New Microbes New Infect. 2021 May;41:100867. doi: 10.1016/j.nmni.2021.100867. Epub 2021 Mar 19.
8
Considerations When Managing Heart Failure during the COVID-19 Pandemic-Consensus from the Taiwan Society of Cardiology.2019冠状病毒病大流行期间心力衰竭管理的考量——台湾心脏病学会共识
Acta Cardiol Sin. 2021 Mar;37(2):125-129. doi: 10.6515/ACS.202103_37(2).20200916A.
9
Cardiac manifestation of corona virus disease 2019: a preliminary report.新型冠状病毒 2019 型心脏病表现：初步报告。
Cardiovasc J Afr. 2021;32(6):297-300. doi: 10.5830/CVJA-2020-061. Epub 2021 Jan 14.
10
COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil.在巴西，新冠疫情隔离措施对炎症性肠病患者产生了负面社会影响，并导致后续护理受到影响。
Ann Gastroenterol. 2021;34(1):39-45. doi: 10.20524/aog.2020.0558. Epub 2020 Nov 26.
本文引用的文献
1
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
2
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.
6
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.新型冠状病毒感染肺炎在中国武汉的早期传播动力学。
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
9
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.致病性人类冠状病毒感染：细胞因子风暴和免疫病理学的成因及后果
Semin Immunopathol. 2017 Jul;39(5):529-539. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2.
10
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.血管紧张素转换酶 2 和血管紧张素 1-7：新的治疗靶点。
Nat Rev Cardiol. 2014 Jul;11(7):413-26. doi: 10.1038/nrcardio.2014.59. Epub 2014 Apr 29.
Zotero 插件